We are live on ! Find out more
MIRO

Miromatrix Medical Inc. Common Stock
MIRO

Delisted

MIRO was delisted on the 12th of December, 2023.

Back to rankings

31 hedge funds and large institutions have $11.1M invested in Miromatrix Medical Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

11% more funds holding

Funds holding: 28 → 31 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less capital invested

Capital invested by funds: $11.2M → $11.1M (-$103K)

Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
7
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FLAM
First Light Asset Management
Minnesota
+$4.42M
2
GS
Gagnon Securities
New York
+$1.53M
3
GA
Gagnon Advisors
New York
+$850K
4
RI
RTW Investments
New York
+$429K
5
PCM
Perkins Capital Management
Minnesota
+$393K

Top Sellers

Rank Fund Capital Flow
1
GIPM
G2 Investment Partners Management
New York
-$488K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$59K
3
TRCT
Tower Research Capital (TRC)
New York
-$20.1K
4
JP Morgan Chase
JP Morgan Chase
New York
-$5K
5
Bank of America
Bank of America
North Carolina
-$96
Name Holding Trade Value Shares
Change 		Change in
Stake
FLAM
1
First Light Asset Management
Minnesota
$3.75M +$4.42M +1,700,000 +318%
GS
2
Gagnon Securities
New York
$2.41M +$1.53M +589,770 +70%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.09M +$36.7K +14,100 +2%
GA
4
Gagnon Advisors
New York
$935K +$850K +326,953 +142%
RI
5
RTW Investments
New York
$748K +$429K +165,222 +59%
GIPM
6
G2 Investment Partners Management
New York
$401K -$488K -187,874 -44%
MC
7
Mayo Clinic
Minnesota
$322K – – –
PCM
8
Perkins Capital Management
Minnesota
$254K +$393K +151,320 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$234K – – –
SFP
10
Sweet Financial Partners
Minnesota
$227K – – –
RJA
11
Raymond James & Associates
Florida
$108K +$167K +64,300 New
MFG
12
Merit Financial Group
Georgia
$102K – – –
LWAM
13
Legacy Wealth Asset Management
Minnesota
$84.9K – – –
Envestnet Asset Management
14
Envestnet Asset Management
Illinois
$80.7K – – –
HWM
15
HighMark Wealth Management
Minnesota
$70.5K +$109K +41,972 New
BlackRock
16
BlackRock
New York
$67K +$3.24K +1,248 +3%
State Street
17
State Street
Massachusetts
$50.4K – – –
WVP
18
Worth Venture Partners
New Jersey
$36.6K +$56.7K +21,800 New
TWM
19
Tradition Wealth Management
Minnesota
$36K +$55.3K +21,275 New
Northern Trust
20
Northern Trust
Illinois
$25.5K – – –
Charles Schwab
21
Charles Schwab
California
$18.5K – – –
US Bancorp
22
US Bancorp
Minnesota
$16.8K – – –
UBS Group
23
UBS Group
Switzerland
$11.7K +$18.1K +6,980 New
HWA
24
HHM Wealth Advisors
Tennessee
$5.88K – – –
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$3K – – –
1
2

MIRO Hedge Fund Activity: Q1 2023 in Review

31 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q1 2023, worth a combined $11.1M — down 0.92% from $11.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MIRO positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was First Light Asset Management, adding an estimated $4.42M. The largest seller was G2 Investment Partners Management, cutting an estimated $488K.

  • 31 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q1 2023, up from 28 in Q4 2022.
  • Funds reported $11.1M of Miromatrix Medical Inc. Common Stock stock for Q1 2023, down 0.92% quarter-over-quarter.
  • 6 funds opened new Miromatrix Medical Inc. Common Stock positions in Q1 2023 and 3 closed out, a net change of +3 holders.
  • The largest Miromatrix Medical Inc. Common Stock buyer in Q1 2023 was First Light Asset Management, an estimated $4.42M added.
  • The largest Miromatrix Medical Inc. Common Stock seller in Q1 2023 was G2 Investment Partners Management, an estimated $488K sold.

Based on aggregated 13F filings for Q1 2023.